VOGLIBOSE 0.2 MG + GLIMEPIRIDE 2 MG + METFORMIN HYDROCHLORIDE 1000 MG (SR)
Manufacturer: Windlas Biotech Limited
Category: Uncategorised
Packing Type: Strip of 10 tablets
Actual MRP: Rs. 150
Discounted Price: Rs. 70
Discount: 53.33%
Active Ingredients:
The combination medicine Voglibose 0.2 mg, Glimepiride 2 mg, and Metformin Hydrochloride 1000 mg (SR) contains the following active ingredients:
- Voglibose
- Glimepiride
- Metformin Hydrochloride
Pharmacological Properties:
Each of the active ingredients in this medicine contributes to its pharmacological properties:
- Voglibose: Voglibose is an alpha-glucosidase inhibitor that helps regulate blood sugar levels by delaying the digestion of carbohydrates.
- Glimepiride: Glimepiride is a sulfonylurea that stimulates the release of insulin from the pancreas, thereby lowering blood sugar levels.
- Metformin Hydrochloride: Metformin is a biguanide that reduces glucose production in the liver and improves insulin sensitivity in the body.
Indications:
This medicine is indicated for the treatment of:
- Type 2 diabetes mellitus
- Hyperglycemia
Contraindications:
Do not use this medicine in the following cases:
- Hypersensitivity to any of the active ingredients
- Severe renal impairment
- Metabolic acidosis
Dosage:
The dosage of Voglibose 0.2 mg + Glimepiride 2 mg + Metformin Hydrochloride 1000 mg (SR) should be determined by a healthcare professional based on individual patient needs. The general recommended dosage is one tablet daily with or after meals.
Side Effects:
Common side effects of this medicine may include:
- Diarrhea
- Nausea
- Abdominal pain
- Hypoglycemia (low blood sugar)
Drug Interactions:
This medicine may interact with the following drugs:
- NSAIDs (nonsteroidal anti-inflammatory drugs)
- Diuretics
- Beta-blockers
Patient Counseling:
Patient counseling points for Voglibose 0.2 mg + Glimepiride 2 mg + Metformin Hydrochloride 1000 mg (SR) include:
- Take the medication with meals as directed
- Monitor blood sugar levels regularly
- Be cautious of signs of hypoglycemia
Clinical Evidence:
Several clinical studies have shown the efficacy and safety of Voglibose, Glimepiride, and Metformin Hydrochloride in the management of type 2 diabetes mellitus. Consult your healthcare provider for more information on specific clinical evidence.
Frequently Asked Questions:
Q: How should I take this medicine?
A: The recommended dosage of Voglibose 0.2 mg + Glimepiride 2 mg + Metformin Hydrochloride 1000 mg (SR) is one tablet daily with or after meals. Follow your healthcare provider’s instructions.
Q: What are the common side effects of this medicine?
A: Common side effects may include diarrhea, nausea, abdominal pain, and hypoglycemia. Consult your doctor if you experience any side effects.
Q: Can this medicine be used in patients with kidney problems?
A: This medicine is contraindicated in patients with severe renal impairment. Consult your doctor for appropriate medication options.
Q: Are there any specific precautions I should take while using this medicine?
A: It is important to monitor your blood sugar levels regularly and be aware of the signs of hypoglycemia. Follow a healthy diet and exercise regimen as recommended by your healthcare provider.
Q: What should I do if I miss a dose of this medicine?
A: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double dose to make up for a missed one.
Q: Can this medicine be taken during pregnancy?
A: Consult your healthcare provider before using this medicine if you are pregnant or planning to become pregnant. The risks and benefits of treatment should be carefully considered in such cases.
